ALT: alanine transaminase; AST: aspartate transaminase; DAO: diamine oxidase; DBIL: direct bilirubin; FAP: fat attenuation parameter; GGT: gamma-glutamyl transpeptidase; HDL: high-density lipoprotein; HOMA-IR: homeostasis model assessment of insulin resistance; IBIL: indirect bilirubin; LDL: low-density lipoprotein; LPS: lipopolysaccharide; LSM: liver stiffness measurement; NAFLD: nonalcoholic fatty liver disease; TBIL: total bilirubin; TC: total cholesterol; TG: triglyceride. Significant P values are indicated in bold font.
Table 4: Effects of metabolic therapy in NAFLD patients with normal or elevated intestinal permeability